National Healthcare Properties, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The last twelve months, up to 18 October 2026, brought 2 filings signed by 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 2 filings here.
Insider buying of National Healthcare Properties, Inc. has been absent for the past year.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Analysts rate National Healthcare Properties, Inc. Buy (bullish), based on 8 analysts. Average price target: US$19.25.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
10 of 10 declarations
National Healthcare Properties, Inc. is a real estate investment trust focused on the healthcare sector. It specializes in the acquisition and management of healthcare-related properties.
Purchases our model currently ranks for the recommendations list.
All recommendations